Trump Should Dust Off Last Year's Drug Reform Plan
By reintroducing his rebate rule, President Trump could lower drug prices by excluding the middlemen who gobble up much of the current price-discount savings.
Don't Believe the Hype: US Carbon Emissions Are Actually Dropping
U.S. emissions reductions rarely make headlines. But that doesn't change the fact that natural gas is helping clean up our environment.
Why Is the U.S. Surrendering the Global IP System to China?
Only immediate attention from the White House can prevent WIPO from becoming dominated by China, which would pose risks to the entire global IP system, and thus to U.S. security and innovation.
IPI Statement in Support of FCC Chairman Pai's C-Band Plan
Sanders' Desire to Destroy Our Free Market Economy Would Doom Democrats This Fall
Most presidential candidates call for change. Sanders is much bolder; he’s calling for a “revolution.”
What Kind of Disrupter Would President Sanders Be?
Being a disrupter could be either positive or negative, depending on whether and how a voter thinks the country needs disrupting.
An Easily Forgotten Point: Price Is Not the Same as Spending
Efforts to control prescription-drug prices by setting prices through a government mandate are not likely to control overall prescription-drug spending.
Direct-to-Consumer Drug Advertising Benefits Companies, but Patients Even More
Advertising is a way companies convey important information to consumers about products that may help them. The return on investment isn't just to drug companies, it's to people who act on that important medical information.
The Carbon Credit Scheme: Greenhouse Gas Credits Don't Help the Environment--Or Consumers
To stay in business, car manufacturers have to please consumers—not the government. And consumers still want gas-powered cars.
Total Records: 1645
